{"url_path":"/sec/afjk/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-028880-index.html","accession_number":"0001493152-26-028880","cik":"0001979005","ticker":"AFJK","issuer_name":"Aimei Health Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-028880-index.html","primary_entity_key":"0001979005","primary_entity_name":"Aimei Health Technology Co., Ltd."},"word_count":482,"has_tables":true,"body_markdown":"Item\n6. Exhibits\n\n \n\nThe\nexhibits listed below are filed as part of this Quarterly Report on Form 10-Q.\n\n \n\nExhibit\nNo.\n \nDescription\n\n3.1\n \n[Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the Registrant on December 7, 2023)](https://www.sec.gov/Archives/edgar/data/1979005/000149315223043918/ex3-1.htm)\n\n4.1\n \n[Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-1/A filed by the Registrant on July 24, 2023)](https://www.sec.gov/Archives/edgar/data/1979005/000149315223025299/ex4-1.htm)\n\n4.2\n \n[Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-1/A filed by the Registrant on July 24, 2023)](https://www.sec.gov/Archives/edgar/data/1979005/000149315223025299/ex4-2.htm)\n\n4.3\n \n[Specimen Rights Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1/A filed by the Registrant on July 24, 2023)](https://www.sec.gov/Archives/edgar/data/1979005/000149315223025299/ex4-3.htm)\n\n4.4\n \n[Rights Agreement, dated December 1, 2023, by and between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Registrant on December 7, 2023)](https://www.sec.gov/Archives/edgar/data/1979005/000149315223043918/ex4-1.htm)\n\n10.1\n \n[First Amendment to Business Combination Agreement dated as of June 6, 2025 (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed by the Registrant on June 11, 2025)](https://www.sec.gov/Archives/edgar/data/1979005/000164117225014697/ex2-1.htm)\n\n31.1\n \n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n31.2\n \n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n32.1*\n \n[Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n32.2*\n \n[Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n101.INS\n \nInline\nXBRL Instance Document.\n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document.\n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document.\n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document.\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\nIn\naccordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1\nand 32.2 herewith are deemed to accompany this Form 10-Q and will not be deemed filed for purposes of Section 18 of the Exchange\nAct. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange\nAct.\n\n \n\n21\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 16, 2026\n\n \n\n \n**Aimei\nHealth Technology Co., Ltd**\n\n \n \n \n\n \nBy:\n*/s/\nJunheng Xie*\n\n \nName:\nJunheng\nXie\n\n \nTitle:\nChief\nExecutive Officer and Director\n\n \n \n(Principal\nExecutive Officer)\n\n \n\n \nBy:\n*/s/\nHeung Ming Wong*\n\n \nName:\nHeung\nMing Wong\n\n \nTitle:\nChief\nFinancial Officer and Director\n\n \n \n(Principal\nAccounting and Financial Officer)\n\n \n\n22"}